D-0294-2026 Class II Ongoing

Recalled by Specialty Process Labs LLC — Phoenix, AZ

FDA drug recall D-0294-2026 was initiated by Specialty Process Labs LLC on Jan 16, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 58 gms.

Recall details

Product Type
Drugs
Report Date
Jan 28, 2026
Initiation Date
Jan 16, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
58 gms

Product description

Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02

Reason for recall

Subpotent Drug

Distribution pattern

U.S. Nationwide

Code information

Lot #H22254-1XV; Exp. 01/31/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0294-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0294-2026. Report a data issue: hello@regdatalab.com.